Radiotherapy-induced lymphocytopenia: Changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms

Journal of Biological Regulators and Homeostatic Agents

Volumn 19, Issue 3-4, 2005, Pages 153-158

  Lissoni, P ^a   Meregalli, S ^a   Bonetto, E ^a   Mancuso, M ^a   Brivio, F ^a   Colciago, M ^b   Gardani, G ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b Hospital of Carate   (Italy)

Author keywords

Lymphocyte subpopulations; Lymphocytes; Pelvic irradiation; Radiotherapy

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CISPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; NATURAL KILLER CELL; RADIATION DOSE; RADIATION RESPONSE; THERAPY EFFECT; TUMOR REGRESSION; UTERINE CERVIX CARCINOMA; BLOOD; ENDOMETRIUM TUMOR; FEMALE GENITAL TRACT TUMOR; IMMUNOLOGY; MIDDLE AGED; RADIATION EXPOSURE; RADIOTHERAPY; UTERINE CERVIX TUMOR;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOPENIA; MIDDLE AGED; RADIOTHERAPY; UTERINE CERVICAL NEOPLASMS;

EID: 33744511428     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chouaib S, Fraedelizi D. The mechanisms of inhibition of human IL-2 production. J Immunol 1982; 129: 2463-7.
2. Atzpodien J, Kirchner H. Cancer, cytokines and cytotoxic cells: Interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr 1990; 68: 1-11.
3. Rosemberg SA. The immunotherapy and gene therapy of cancer. J Clin Oncol 1992; 10: 180-91.
4. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. J Exp Med 1982; 155: 1823-41.
5. Brivio F, Lissoni P, Tisi E, et al. Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients. Oncology 1992; 49: 215-8.
6. Nichols P, Ramsden CW, Ward U, Sedman PC, Primrose JN. Perioperative immunotherapy with recombinant interleukin-2 in patients undergoing surgery for colorectal cancer. Cancer Res 1992; 52: 5765-9.
7. Lissoni P, Fumagalli L, Paolorossi F, Mandalà M. Changes in lymphocyte number during cancer chemotherapy and their relation to clinical response. Int J Biol Markers 1999; 14: 115-7.
8. Miller GM, Kajioka EH, Andres ML, Gridley DS. Dose and timing of total-body irradiation mediate tumor progression and immunomodulation. Oncol Res 2002; 13: 9-18.
9. Yamazaki H, Yoshioka Y, Inoue T, et al. Changes in natural killer cell activity by external radiotherapy and/or brachytherapy. Oncol Res 2002; 9: 359-63.
10. Popanda O, Ebbeler R, Twardella D, et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 1216-25.
11. Riesco A. Five-year cancer cure: Relation to total amount of peripheral lymphocytes and neutrophils. Cancer 1970; 25: 135-40.
12. Maltoni M, Pirovano M, Nanni O, et al. Biological indices predictive of survival in 519 italian terminally ill cancer patients. J Pain Symptom Manage 1997; 13: 1-9.